News from Institute for Energy Technology
Nuclear Technology and Health
- Digitalization used in decommissioning
- The first week of December, The Institute of Energy Technology gathered some of the world's leading researchers and project leaders in decommissioning at Lillehammer. Up to 90,000 will work directly or indirectly with decommissioning over the next decade. Their experiences must be shared with others, and the professional communities have to come to terms with each other on best practices.
- IFE decides to close the Halden Reactor, but continues nuclear research activities
- IFE's Board of Directors has decided to permanently close the Halden Reactor and to start decommissioning the reactor. IFE will continue its nuclear research activities, with focus on activities that do not depend on the reactor being operational. The closure of the reactor will not affect IFE's other operations.
- Press release: Increased governmental funding to handle Norway's nuclear waste
- The Norwegian Government today published the national budget proposal for 2018. IFE is pleased that the Norwegian State is taking responsibility for the handling of nuclear waste and the challenges associated with future decommissioning of research reactor facilities in Norway.
- Major investment in radiopharmaceuticals at IFE
- The radiopharmaceutical company Algeta ASA has decided to place the pharmaceutical production of their new cancer treatment, Alpharadin, to IFE’s facilities at Kjeller.
Also in this section
- IFE seeks PhD Candidate within silane decomposition reactor technology
- The Institute for Energy Technology (IFE) is an independent international research foundation based in Kjeller near Oslo. IFE is at the forefront of several research fields within energy research, environmental and nuclear technology, and develops new technological solutions for industry and the public sector in more than 30 countries. IFE has about 600 employees and an annual turnover of about NOK 850 Million.